Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and [T.sub.reg] cells

Although immune mechanisms can suppress tumour growth (1,2), tumours establish potent, overlapping mechanisms that mediate immune evasion (3-6). Emerging evidence suggests a link between angiogenesis and the tolerance of tumours to immune mechanisms (7-10). Hypoxia, a condition that is known to driv...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 2011-07, Vol.475 (7355), p.226
Main Authors: Facciabene, Andrea, Peng, Xiaohui, Hagemann, Ian S, Balint, Klara, Barchetti, Andrea, Wang, Li-Ping, Gimotty, Phyllis A, Gilks, C. Blake, Lal, Priti, Zhang, Lin, Coukos, George
Format: Article
Language:English
Subjects:
Genetic aspects
Health aspects
Hypoxia
Neovascularization
Physiological aspects
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although immune mechanisms can suppress tumour growth (1,2), tumours establish potent, overlapping mechanisms that mediate immune evasion (3-6). Emerging evidence suggests a link between angiogenesis and the tolerance of tumours to immune mechanisms (7-10). Hypoxia, a condition that is known to drive angiogenesis in tumours, results in the release of damage-associated pattern molecules, which can trigger the rejection of tumours by the immune system (11). Thus, the counter-activation of tolerance mechanisms at the site of tumour hypoxia would be a crucial condition for maintaining the immunological escape of tumours. However, a direct link between tumour hypoxia and tolerance through the recruitment of regulatory cells has not been established. We proposed that tumour hypoxia induces the expression of chemotactic factors that promote tolerance. Here we show that tumour hypoxia promotes the recruitment of regulatory T ([T.sub.reg]) cells through induction of expression of the chemokine CC-chemokine ligand 28 (CCL28), which, in turn, promotes tumour tolerance and angiogenesis. Thus, peripheral immune tolerance and angiogenesis programs are closely connected and cooperate to sustain tumour growth.
ISSN:0028-0836
1476-4687
DOI:10.1038/nature10169